U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07791368) titled 'Developing and Testing the Efficacy of AI-Chatbot-Based' on Aug. 12.
Brief Summary: this study aims to develop the Calm-Mind-Recovery-Journey AI-Chatbot delivering BMS-MC therapy for breast cancer survivors and examine its feasibility, acceptability, safety, and preliminary effects of holistic well-being and depressive levels, and coping skills (mindfulness status, self-compassion, emotional regulations), and breast cancer-specific QOL. The experiences of participants using AI-Chatbot will be explored.
Study Start Date: Aug. 01, 2027
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
BEHAVIORAL: AIAI-Chatbot Cal...